CONCORD
Start SIP
Invest Now
Start SIP in CONCORD
Performance
- Low
- ₹0
- High
- ₹0
- 52 Week Low
- ₹0
- 52 Week High
- ₹0
- Open Price₹0
- Previous Close₹0
- Volume
Investment Returns
- Over 1 Month -0.5%
- Over 3 Month + 21.54%
- Over 6 Month + 174.54%
- Over 1 Year + 130.76%
Smart Investing Starts Here Start SIP with Concord Drugs for Steady Growth!
Concord Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
Concord Drugs Financials
Concord Drugs Technicals
EMA & SMA
Current Price
₹85.08
+
4.05
(5%)
- Bearish Moving Average 0
- Bullish Moving Average 0
- 20 Day
- ₹78.60
- 50 Day
- ₹74.63
- 100 Day
- ₹67.39
- 200 Day
- ₹57.63
Resistance and Support
84.26
- R3 88.29
- R2 86.69
- R1 85.86
- S1 83.43
- S2 81.83
- S3 81.00
Concord Drugs Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-13 | Quarterly Results | |
| 2025-08-08 | Quarterly Results | |
| 2025-07-03 | Preferential issue of shares | |
| 2025-06-27 | Preferential Issue of shares & Others | Inter-alia, to consider 1. the date, time, and venue for convening an ExtraOrdinary General Meeting of the Company. 2. Other business matters. |
| 2025-05-23 | Audited Results |
Concord Drugs F&O
About Concord Drugs
- NSE Symbol
- CONCORD
- BSE Symbol
- 538965
- Chairman & Managing Director
- Mr. Sudhir Vaid
- ISIN
- INE858L01010
Similar Stocks to Concord Drugs
Concord Drugs FAQs
Concord Drugs share price is ₹85 As on 12 December, 2025 | 22:58
The Market Cap of Concord Drugs is ₹112.1 Cr As on 12 December, 2025 | 22:58
The P/E ratio of Concord Drugs is 194.7 As on 12 December, 2025 | 22:58
The PB ratio of Concord Drugs is 3 As on 12 December, 2025 | 22:58
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.